Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants

Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants Publisher Pubmed

Noori M¹ ; Nejadghaderi SA^{2, 3} ; Rezaei N^{4, 5, 6}

Show Affiliations

1. Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2. Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran
3. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
6. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Infection Control and Hospital Epidemiology Published:2022

Abstract

[No abstract available]

Style	Citing Format
MLA	Noori M, Nejadghaderi SA, Rezaei N. "Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants." Infection Control and Hospital Epidemiology, vol. 43, no. 8, 2022, pp. 1091-1092.
APA	Noori M, Nejadghaderi SA, Rezaei N (2022). Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants. Infection Control and Hospital Epidemiology, 43(8), 1091-1092.
Chicago	Noori M, Nejadghaderi SA, Rezaei N. "Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants." Infection Control and Hospital Epidemiology 43, no. 8 (2022): 1091-1092.
Harvard	Noori M, Nejadghaderi SA, Rezaei N (2022) 'Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants', Infection Control and Hospital Epidemiology, 43(8), pp. 1091-1092.
Vancouver	Noori M, Nejadghaderi SA, Rezaei N. Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants. Infection Control and Hospital Epidemiology. 2022;43(8):1091-1092.
BibTex	@article{ author = {Noori M and Nejadghaderi SA and Rezaei N}, title = {Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants}, journal = {Infection Control and Hospital Epidemiology}, volume = {43}, number = {8}, pages = {1091-1092}, year = {2022} }
RIS	TY - JOUR AU - Noori M AU - Nejadghaderi SA AU - Rezaei N TI - Original Antigenic Sin: A Potential Threat Beyond the Development of Booster Vaccination Against Novel Sars-Cov-2 Variants JO - Infection Control and Hospital Epidemiology VL - 43 IS - 8 SP - 1091 EP - 1092 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract